TITLE

Evaluation of Meningitis Surveillance Before Introduction of Serogroup A Meningococcal Conjugate Vaccine -- Burkina Faso and Mali

AUTHOR(S)
Djingarey, Mamoudou; Kandolo, Denis; Lingani, Clement; Diomandé, Fabien; Medah, Isaïe; Kambou, Ludovic; Tarbangdo, Felix; Diarra, Seydou; Touré, Kandioura; Bougoudogo, Flabou; Mandal, Sema; Novak, Ryan T.; Cohn, Amanda C.; Clark, Thomas A.; Messonnier, Nancy E.
PUB. DATE
December 2012
SOURCE
MMWR: Morbidity & Mortality Weekly Report;12/21/2012, Vol. 61 Issue 50, p1025
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article discusses the assessment of meningitis surveillance before the conduct of a serogroup A Neisseria meningitidis meningococcal conjugate vaccination campaign in Burkina Faso and Mali. It claims that a solid meningitis surveillance is important for assessing the effect of the PsA-TT (MenAfriVac) as it was licensed based on safety and immunogenicity data. The data were collected by the World Health Organization and the U.S. Centers for Disease Control and Prevention (CDC).
ACCESSION #
84634848

 

Related Articles

  • Changes in Neisseria meningitidis Disease Epidemiology in the United States, 1998-2007: Implications for Prevention of Meningococcal Disease. Cohn, Amanda C.; MacNeil, Jessica R.; Harrison, Lee H.; Hatcher, Cynthia; Theodore, Jordan; Schmidt, Mark; Pondo, Tracy; Arnold, Kathryn E.; Baumbach, Joan; Bennett, Nancy; Craig, Allen S.; Farley, Monica; Gershman, Ken; Petit, Susan; Lynfield, Ruth; Reingold, Arthur; Schaffner, William; Shutt, Kathleen A.; Zell, Elizabeth R.; Mayer, Leonard W. // Clinical Infectious Diseases;1/15/2010, Vol. 50 Issue 2, p184 

    Background. In January 2005, a quadrivalent (serogroups A, C , Y, and W-135) meningococcal conjugate vaccine was licensed for use in adolescents. This report describes the epidemiologic features of meningococcal disease in the United States from January 1998 through December 2007, before and...

  • CDC issues new vaccine recommendations.  // Alternative Medicine Alert;Nov2009 Pharmacology Watch Supp, p1 

    The article highlights the changes made by the U.S. Centers for Disease Control and Prevention on its vaccine recommendations. The Advisory Committee on Immunization Practices (ACIP) suggests the revaccination of people who are at prolonged increased risk for meningococcaI disease. The...

  • Exposure to Patients With Meningococcal Disease on Aircraft--United States, 1999-2001. Layton, M.; Cartter, M.; Bresnitz, E.; Wiersma, S.; Mascola, L. // JAMA: Journal of the American Medical Association;7/11/2001, Vol. 286 Issue 2, p160 

    Presents a case of air travel-associated meningococcal disease, or neisseria meningitidis, and guidelines for the management of persons potentially exposed to meningococcus during air travel. Details of the case report; Surveillance system employed by the United States Centers for Disease...

  • New meningococcal vaccine urged for the nation's preteens.  // Cortlandt Forum;7/25/2005, Vol. 18 Issue 7, p18 

    Reports that the U.S. Centers for Disease Control and Prevention has called for routine meningococcal vaccination of all children aged eleven to twelve. Development of the vaccine by Sanofi Pasteur company; Coverage of the inoculation drive; Symptoms of the disease.

  • CDC issues new vaccine recommendations. Elliott, William T. // Infectious Disease Alert;Nov2009 Infectious D, p1 

    The article reports on revisions made by the U.S. Centers for Disease Control and Prevention (CDC) on its vaccine recommendations. According to the Advisory Committee on Immunization Practices (ACIP), revaccination is advised for persons at prolonged increased risk for meningococcal disease....

  • Diseases/Health Data. Coleman, Denise Youngblood // Cape Verde Country Review;2013, p153 

    The article presents updates on diseases and health in the Republic of Cape Verde as of July 2013 including an outbreak of meningitis on several central, east, and west African countries, vaccines recommended by the U.S. Centers for Disease Control and Prevention as appropriate for age, and...

  • CDC issues new vaccine recommendations. Elliott, William T. // Infectious Disease Alert;Nov2009, Vol. 29 Issue 2, p1 

    The article focuses on the revised vaccine recommendations issued by the U.S. Centers for Disease Control and Prevention (CDC) in October 2009. The Advisory Committee on Immunization Practices (ACIP) recommends revaccination of people who have prolonged increased risk for meningococcal disease...

  • Meningococcal vaccine and Guillain Barre syndrome.  // WHO Drug Information;2005, Vol. 19 Issue 4, p290 

    The article reports that the U.S. Food and Drug Administration and Centers for Disease Control and Prevention have been alerting consumers and health care providers to five reports of Guillain Barre syndrome following administration of meningococcal conjugate vaccine. This Guillain Barre...

  • Flu season seen relatively mild; fears of anthrax not fueling run on ERs. Parker, Che // AHA News;1/14/2002, Vol. 38 Issue 1, p9 

    Provides a report by the United States (U.S.) Centers for Disease Control and Prevention on the mild flu season in the U.S. Number of respiratory specimens that were tested positive for influenza by the World Health Organization in December 2001; Proportion of deaths attributed to influenza and...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics